Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2583]

First-in-class targeted microRNA therapy slows cancer tumour growth

First-in-class targeted microRNA therapy slows cancer tumour growth

New genes and natural toxins offer hope for cancer patients unresponsive to chemotherapy

New genes and natural toxins offer hope for cancer patients unresponsive to chemotherapy

European Commission approves pembrolizumab plus trastuzumab and chemotherapy as first-line treatment for HER2-positive advanced gastric or gastroesophageal junction adenocarcinoma expressing PD-L1

European Commission approves pembrolizumab plus trastuzumab and chemotherapy as first-line treatment for HER2...

AI predictions for colorectal cancer: One step closer to efficient precision oncology

AI predictions for colorectal cancer: One step closer to efficient precision oncology

Gene therapy for brain tumour shows promising early results in humans

Gene therapy for brain tumour shows promising early results in humans

Researchers publish key findings about cell proteins to determine effectiveness of immunotherapy for colon cancer

Researchers publish key findings about cell proteins to determine effectiveness of immunotherapy for colon cancer

Expanding the impact of CAR T cell therapy: An immunotherapy strategy against all blood cancers

Expanding the impact of CAR T cell therapy: An immunotherapy strategy against all blood cancers

Antioxidants stimulate blood flow in tumours

Antioxidants stimulate blood flow in tumours

A new approach to stop cancer growth?

A new approach to stop cancer growth?

Researchers help identify mechanisms by which multiple myeloma escapes targeted immunotherapy

Researchers help identify mechanisms by which multiple myeloma escapes targeted immunotherapy

More from ecancer